PFIZER INC Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
PFIZER INC (PFE) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$237.00 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2026-08-04
- PFIZER INC net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-06-28 was -$237.00M, a 108.09% decline year-over-year.
- PFIZER INC net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-03-29 was $2.70B, a 9.32% decline year-over-year.
- PFIZER INC net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$1.64B, a 492.34% decline year-over-year.
- PFIZER INC net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-09-28 was $3.55B, a 20.63% decline year-over-year.
- PFIZER INC net income (loss), including portion attributable to noncontrolling interest for fiscal 2025 was $7.81B, a 3.10% decline from fiscal 2024.
- PFIZER INC net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was $8.06B, a 273.59% increase from fiscal 2023.
- PFIZER INC net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was $2.16B, a 93.13% decline from fiscal 2022.
- PFIZER INC net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was $31.41B, a 42.60% increase from fiscal 2021.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-28 | -$237.00M 10-Q · filed 2026-08-04 | $2.46B 10-Q · filed 2026-08-04 | $819.00M derived: sum of 3 quarters · filed 2026-08-04 | $4.37B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-29 | $2.70B 10-Q · filed 2026-05-05 | $1.06B derived: sum of 2 quarters · filed 2026-05-05 | $4.61B derived: sum of 3 quarters · filed 2026-05-05 | $7.53B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | -$1.64B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.91B derived: sum of 2 quarters · filed 2026-02-26 | $4.84B derived: sum of 3 quarters · filed 2026-08-04 | $7.81B 10-K · filed 2026-02-26 | ||||
| 2025-09-28 | $3.55B 10-Q · filed 2025-11-04 | $6.48B derived: sum of 2 quarters · filed 2026-08-04 | $9.45B 10-Q · filed 2025-11-04 | $9.87B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-29 | $2.93B 10-Q · filed 2026-08-04 | $5.90B 10-Q · filed 2026-08-04 | $6.32B derived: sum of 3 quarters · filed 2026-08-04 | $10.79B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-30 | $2.97B 10-Q · filed 2026-05-05 | $3.39B derived: sum of 2 quarters · filed 2026-05-05 | $7.86B derived: sum of 3 quarters · filed 2026-05-05 | $7.91B derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $418.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.89B derived: sum of 2 quarters · filed 2026-02-26 | $4.94B derived: sum of 3 quarters · filed 2026-02-26 | $8.06B 10-K · filed 2026-02-26 | ||||
| 2024-09-29 | $4.47B 10-Q · filed 2025-11-04 | $4.52B derived: sum of 2 quarters · filed 2025-11-04 | $7.64B 10-Q · filed 2025-11-04 | $4.28B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $48.00M 10-Q · filed 2025-08-05 | $3.17B 10-Q · filed 2025-08-05 | -$189.00M derived: sum of 3 quarters · filed 2026-02-26 | -$2.56B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $3.12B 10-Q · filed 2025-05-05 | -$237.00M derived: sum of 2 quarters · filed 2026-02-26 | -$2.61B derived: sum of 3 quarters · filed 2026-02-26 | -$275.00M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | -$3.36B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$5.74B derived: sum of 2 quarters · filed 2026-02-26 | -$3.40B derived: sum of 3 quarters · filed 2026-02-26 | $2.16B 10-K · filed 2026-02-26 | ||||
| 2023-10-01 | -$2.38B 10-Q · filed 2024-11-04 | -$38.00M derived: sum of 2 quarters · filed 2024-11-04 | $5.52B 10-Q · filed 2024-11-04 | $10.52B derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-07-02 | $2.34B 10-Q · filed 2024-08-05 | $7.89B 10-Q · filed 2024-08-05 | $12.90B derived: sum of 3 quarters · filed 2025-02-27 | $21.52B derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-04-02 | $5.56B 10-Q · filed 2024-05-08 | $10.56B derived: sum of 2 quarters · filed 2025-02-27 | $19.18B derived: sum of 3 quarters · filed 2025-02-27 | $29.09B derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | $5.00B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $13.63B derived: sum of 2 quarters · filed 2025-02-27 | $23.54B derived: sum of 3 quarters · filed 2025-02-27 | $31.41B 10-K · filed 2025-02-27 | ||||
| 2022-10-02 | $8.62B 10-Q · filed 2023-11-08 | $18.53B derived: sum of 2 quarters · filed 2023-11-08 | $26.40B 10-Q · filed 2023-11-08 | $29.80B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-07-03 | $9.91B 10-Q · filed 2023-08-09 | $17.78B 10-Q · filed 2023-08-09 | $21.17B derived: sum of 3 quarters · filed 2024-02-22 | $29.33B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-04-03 | $7.87B 10-Q · filed 2023-05-10 | $11.26B derived: sum of 2 quarters · filed 2024-02-22 | $19.42B derived: sum of 3 quarters · filed 2024-02-22 | $25.01B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | $3.39B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $11.55B derived: sum of 2 quarters · filed 2024-02-22 | $17.14B derived: sum of 3 quarters · filed 2024-02-22 | $22.02B 10-K · filed 2024-02-22 | ||||
| 2021-10-03 | $8.16B 10-Q · filed 2022-11-09 | $13.75B derived: sum of 2 quarters · filed 2022-11-09 | $18.63B 10-Q · filed 2022-11-09 | $19.49B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-07-04 | $5.59B 10-Q · filed 2022-08-10 | $10.47B 10-Q · filed 2022-08-10 | $11.33B derived: sum of 3 quarters · filed 2023-02-23 | $12.81B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-04-04 | $4.89B 10-Q · filed 2022-05-11 | $5.74B derived: sum of 2 quarters · filed 2023-02-23 | $7.22B derived: sum of 3 quarters · filed 2023-02-23 | $10.72B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | $857.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $2.33B derived: sum of 2 quarters · filed 2023-02-23 | $5.83B derived: sum of 3 quarters · filed 2023-02-23 | $9.20B 10-K · filed 2023-02-23 | $9.65B 10-K · filed 2021-02-25 | |||
| 2020-09-27 | $1.48B 10-Q · filed 2021-11-12 | $2.20B 10-Q · filed 2020-11-05 | $4.97B derived: sum of 2 quarters · filed 2021-11-12 | $8.34B 10-Q · filed 2021-11-12 | $9.05B 10-Q · filed 2020-11-05 | $7.77B derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-06-28 | $3.50B 10-Q · filed 2021-08-12 | $3.43B 10-Q · filed 2020-08-06 | $6.86B 10-Q · filed 2021-08-12 | $6.84B 10-Q · filed 2020-08-06 | $6.29B derived: sum of 3 quarters · filed 2022-02-24 | $13.97B derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-03-29 | $3.36B 10-Q · filed 2021-05-13 | $3.41B 10-Q · filed 2020-05-07 | $2.79B derived: sum of 2 quarters · filed 2022-02-24 | $10.48B derived: sum of 3 quarters · filed 2022-02-24 | $15.53B derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2019-12-31 | -$572.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $7.11B derived: sum of 2 quarters · filed 2022-02-24 | $12.17B derived: sum of 3 quarters · filed 2022-02-24 | $16.06B 10-K · filed 2022-02-24 | $16.30B 10-K · filed 2020-02-27 | |||
| 2019-09-29 | $7.68B 10-Q · filed 2020-11-05 | $12.74B derived: sum of 2 quarters · filed 2020-11-05 | $16.63B 10-Q · filed 2020-11-05 | $16.25B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $5.06B 10-Q · filed 2020-08-06 | $8.95B 10-Q · filed 2020-08-06 | $8.56B derived: sum of 3 quarters · filed 2021-02-25 | $12.68B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $3.89B 10-Q · filed 2020-05-07 | $3.51B derived: sum of 2 quarters · filed 2021-02-25 | $7.63B derived: sum of 3 quarters · filed 2021-02-25 | $11.51B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | -$383.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $3.74B derived: sum of 2 quarters · filed 2021-02-25 | $7.62B derived: sum of 3 quarters · filed 2021-02-25 | $11.19B 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $4.12B 10-Q · filed 2019-11-07 | $8.00B derived: sum of 2 quarters · filed 2019-11-07 | $11.57B 10-Q · filed 2019-11-07 | $23.86B derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-07-01 | $3.88B 10-Q · filed 2019-08-08 | $7.45B 10-Q · filed 2019-08-08 | $19.74B derived: sum of 3 quarters · filed 2020-02-27 | $22.60B derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-04-01 | $3.57B 10-Q · filed 2019-05-09 | $15.86B derived: sum of 2 quarters · filed 2020-02-27 | $18.72B derived: sum of 3 quarters · filed 2020-02-27 | $21.80B derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $12.29B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $15.15B derived: sum of 2 quarters · filed 2020-02-27 | $18.23B derived: sum of 3 quarters · filed 2020-02-27 | $21.36B 10-K · filed 2020-02-27 | ||||
| 2017-10-01 | $2.86B 10-Q · filed 2018-11-08 | $5.94B derived: sum of 2 quarters · filed 2018-11-08 | $9.07B 10-Q · filed 2018-11-08 | $9.85B derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-07-02 | $3.08B 10-Q · filed 2018-08-09 | $6.21B 10-Q · filed 2018-08-09 | $6.99B derived: sum of 3 quarters · filed 2019-02-28 | $8.34B derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-04-02 | $3.13B 10-Q · filed 2018-05-10 | $3.91B derived: sum of 2 quarters · filed 2019-02-28 | $5.27B derived: sum of 3 quarters · filed 2019-02-28 | $7.33B derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | $781.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $2.14B derived: sum of 2 quarters · filed 2019-02-28 | $4.20B derived: sum of 3 quarters · filed 2019-02-28 | $7.25B 10-K · filed 2019-02-28 | ||||
| 2016-10-02 | $1.35B 10-Q · filed 2017-11-09 | $1.32B 10-Q · filed 2016-11-10 | $3.42B derived: sum of 2 quarters · filed 2017-11-09 | $6.46B 10-Q · filed 2017-11-09 | $6.38B 10-Q · filed 2016-11-10 | $6.30B derived: sum of 4 quarters · filed 2018-02-22 | ||
| 2016-07-03 | $2.06B 10-Q · filed 2017-08-10 | $2.04B 10-Q · filed 2016-08-11 | $5.11B 10-Q · filed 2017-08-10 | $5.06B 10-Q · filed 2016-08-11 | $4.94B derived: sum of 3 quarters · filed 2018-02-22 | $7.08B derived: sum of 4 quarters · filed 2018-02-22 | ||
| 2016-04-03 | $3.05B 10-Q · filed 2017-05-11 | $3.03B 10-Q · filed 2016-05-12 | $2.88B derived: sum of 2 quarters · filed 2018-02-22 | $5.02B derived: sum of 3 quarters · filed 2018-02-22 | $7.65B derived: sum of 4 quarters · filed 2018-02-22 | |||
| 2015-12-31 | -$169.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $1.97B derived: sum of 2 quarters · filed 2018-02-22 | $4.61B derived: sum of 3 quarters · filed 2018-02-22 | $6.99B 10-K · filed 2018-02-22 | ||||
| 2015-09-27 | $2.14B 10-Q · filed 2016-11-10 | $4.77B derived: sum of 2 quarters · filed 2016-11-10 | $7.16B 10-Q · filed 2016-11-10 | $8.39B derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-28 | $2.63B 10-Q · filed 2016-08-11 | $5.02B 10-Q · filed 2016-08-11 | $6.25B derived: sum of 3 quarters · filed 2017-02-23 | $8.92B derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-03-29 | $2.38B 10-Q · filed 2016-05-12 | $3.62B derived: sum of 2 quarters · filed 2017-02-23 | $6.29B derived: sum of 3 quarters · filed 2017-02-23 | $9.21B derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2014-12-31 | $1.24B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $3.91B derived: sum of 2 quarters · filed 2017-02-23 | $6.83B derived: sum of 3 quarters · filed 2017-02-23 | $9.17B 10-K · filed 2017-02-23 | ||||
| 2014-09-28 | $2.67B 10-Q · filed 2015-11-05 | $5.59B derived: sum of 2 quarters · filed 2015-11-05 | $7.93B 10-Q · filed 2015-11-05 | $10.51B derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-29 | $2.92B 10-Q · filed 2015-08-06 | $5.26B 10-Q · filed 2015-08-06 | $7.83B derived: sum of 3 quarters · filed 2016-02-29 | $10.43B derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-30 | $2.34B 10-Q · filed 2015-05-07 | $4.91B derived: sum of 2 quarters · filed 2016-02-29 | $7.51B derived: sum of 3 quarters · filed 2016-02-29 | $21.64B derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $2.57B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $5.17B derived: sum of 2 quarters · filed 2016-02-29 | $19.31B derived: sum of 3 quarters · filed 2016-02-29 | $22.07B 10-K · filed 2016-02-29 | ||||
| 2013-09-29 | $2.60B 10-Q · filed 2014-11-06 | $16.73B derived: sum of 2 quarters · filed 2014-11-06 | $19.50B 10-Q · filed 2014-11-06 | $25.82B derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-06-30 | $14.13B 10-Q · filed 2014-08-07 | $16.90B 10-Q · filed 2014-08-07 | $23.22B derived: sum of 3 quarters · filed 2015-02-27 | $26.43B derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-03-31 | $2.77B 10-Q · filed 2014-05-08 | $9.09B derived: sum of 2 quarters · filed 2015-02-27 | $12.30B derived: sum of 3 quarters · filed 2015-02-27 | $15.56B derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2012-12-31 | $6.32B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $9.54B derived: sum of 2 quarters · filed 2015-02-27 | $12.79B derived: sum of 3 quarters · filed 2015-02-27 | $14.60B 10-K · filed 2015-02-27 | ||||
| 2012-09-30 | $3.21B 10-Q · filed 2013-11-08 | $6.47B derived: sum of 2 quarters · filed 2013-11-08 | $8.28B 10-Q · filed 2013-11-08 | $9.72B derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-07-01 | $3.26B 10-Q · filed 2013-08-09 | $5.06B 10-Q · filed 2013-08-09 | $6.51B derived: sum of 3 quarters · filed 2014-02-28 | $10.26B derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-04-01 | $1.80B 10-Q · filed 2013-05-10 | $3.25B derived: sum of 2 quarters · filed 2014-02-28 | $7.00B derived: sum of 3 quarters · filed 2014-02-28 | $9.62B derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $1.45B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $5.20B derived: sum of 2 quarters · filed 2014-02-28 | $7.82B derived: sum of 3 quarters · filed 2014-02-28 | $10.05B 10-K · filed 2014-02-28 | $10.05B 10-K · filed 2012-02-28 | |||
| 2011-10-02 | $3.75B 10-Q · filed 2012-11-09 | $6.37B derived: sum of 2 quarters · filed 2012-11-09 | $8.60B 10-Q · filed 2012-11-09 | $11.50B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-07-03 | $2.62B 10-Q · filed 2011-08-11 | $4.85B 10-Q · filed 2012-08-09 | $7.75B derived: sum of 3 quarters · filed 2013-02-28 | $8.62B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-04-03 | $2.23B 10-Q · filed 2012-05-10 | $5.13B derived: sum of 2 quarters · filed 2013-02-28 | $6.00B derived: sum of 3 quarters · filed 2013-02-28 | $8.49B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $2.90B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $3.77B derived: sum of 2 quarters · filed 2013-02-28 | $6.25B derived: sum of 3 quarters · filed 2013-02-28 | $8.29B 10-K · filed 2013-02-28 | $8.29B 10-K · filed 2011-02-28 | |||
| 2010-10-03 | $871.00M 10-Q · filed 2011-11-10 | $3.36B derived: sum of 2 quarters · filed 2011-11-10 | $5.39B 10-Q · filed 2011-11-10 | $6.16B derived: sum of 4 quarters · filed 2012-02-28 | ||||
| 2010-07-04 | $2.48B 10-Q · filed 2011-08-11 | $4.52B 10-Q · filed 2011-08-11 | $5.29B derived: sum of 3 quarters · filed 2012-02-28 | $8.17B derived: sum of 4 quarters · filed 2012-02-28 | ||||
| 2010-04-04 | $2.04B 10-Q · filed 2011-05-12 | $2.80B derived: sum of 2 quarters · filed 2012-02-28 | $5.68B derived: sum of 3 quarters · filed 2012-02-28 | $7.95B derived: sum of 4 quarters · filed 2012-02-28 | ||||
| 2009-12-31 | $766.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $3.65B derived: sum of 2 quarters · filed 2012-02-28 | $5.91B derived: sum of 3 quarters · filed 2012-02-28 | $8.64B 10-K · filed 2012-02-28 | $8.64B 10-K · filed 2010-02-26 | |||
| 2009-09-27 | $2.88B 10-Q · filed 2010-11-12 | $5.15B derived: sum of 2 quarters · filed 2010-11-12 | $7.88B 10-Q · filed 2010-11-12 | $8.15B derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-06-28 | $2.27B 10-Q · filed 2010-08-12 | $5.00B 10-Q · filed 2010-08-12 | $5.27B derived: sum of 3 quarters · filed 2011-02-28 | $7.55B derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-03-29 | $2.73B 10-Q · filed 2010-05-13 | $3.00B derived: sum of 2 quarters · filed 2011-02-28 | $5.29B derived: sum of 3 quarters · filed 2011-02-28 | $8.07B derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2008-12-31 | $271.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $2.56B derived: sum of 2 quarters · filed 2011-02-28 | $5.34B derived: sum of 3 quarters · filed 2011-02-28 | $8.13B 10-K · filed 2011-02-28 | ||||
| 2008-09-28 | $2.28B 10-Q · filed 2009-11-05 | $5.07B derived: sum of 2 quarters · filed 2009-11-05 | $7.86B 10-Q · filed 2009-11-05 | |||||
| 2008-06-29 | $2.78B 10-Q · filed 2009-08-06 | $5.57B 10-Q · filed 2009-08-06 | ||||||
| 2007-12-31 | $8.19B 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |